Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 22, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharma to Present at the Evercore ISI 4th Annual HealthCONx Conference

CRANBURY, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
November 12, 2021 07:15 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights

CRANBURY, N.J., Nov. 12, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a clinical-stage oncology company pioneering the discovery and development of small molecule therapies...
September 09, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Appoints Tim Smith as Senior Vice President, Head of Corporate Development

CRANBURY, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
September 02, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

CRANBURY, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
August 13, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights

Continued enrollment in Phase 1/2 trial of first-in-class p53 Y220C reactivator PC14586 CRANBURY, N.J., Aug. 13, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a...
June 09, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Announces Participation at the Bank of America Securities 2021 Napa Biopharma Virtual Conference

CRANBURY, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
June 03, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Announces Participation at the Goldman Sachs Annual Healthcare Conference

CRANBURY, N.J., June 03, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
May 14, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Reports First Quarter 2021 Financial Results and Corporate Highlights

Presented late breaking preclinical data on PC14586, the Company’s first-in-class, tumor-agnostic, investigational small molecule p53 Y220C reactivator at the American Association for Cancer Research...
May 05, 2021 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Announces Participation at the Bank of America Healthcare Conference

CRANBURY, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
April 10, 2021 13:31 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021

PC14586 selectively stabilizes the p53 Y220C mutant and restores p53 activityRobust in vivo tumor regression observed with once daily oral dosingPharmacodynamic biomarkers of p53 activation developed...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right